Quagliariello, V.; Bisceglia, I.; Berretta, M.; Iovine, M.; Canale, M.L.; Maurea, C.; Giordano, V.; Paccone, A.; Inno, A.; Maurea, N.
PCSK9 Inhibitors in Cancer Patients Treated with Immune-Checkpoint Inhibitors to Reduce Cardiovascular Events: New Frontiers in Cardioncology. Cancers 2023, 15, 1397.
https://doi.org/10.3390/cancers15051397
AMA Style
Quagliariello V, Bisceglia I, Berretta M, Iovine M, Canale ML, Maurea C, Giordano V, Paccone A, Inno A, Maurea N.
PCSK9 Inhibitors in Cancer Patients Treated with Immune-Checkpoint Inhibitors to Reduce Cardiovascular Events: New Frontiers in Cardioncology. Cancers. 2023; 15(5):1397.
https://doi.org/10.3390/cancers15051397
Chicago/Turabian Style
Quagliariello, Vincenzo, Irma Bisceglia, Massimiliano Berretta, Martina Iovine, Maria Laura Canale, Carlo Maurea, Vienna Giordano, Andrea Paccone, Alessandro Inno, and Nicola Maurea.
2023. "PCSK9 Inhibitors in Cancer Patients Treated with Immune-Checkpoint Inhibitors to Reduce Cardiovascular Events: New Frontiers in Cardioncology" Cancers 15, no. 5: 1397.
https://doi.org/10.3390/cancers15051397
APA Style
Quagliariello, V., Bisceglia, I., Berretta, M., Iovine, M., Canale, M. L., Maurea, C., Giordano, V., Paccone, A., Inno, A., & Maurea, N.
(2023). PCSK9 Inhibitors in Cancer Patients Treated with Immune-Checkpoint Inhibitors to Reduce Cardiovascular Events: New Frontiers in Cardioncology. Cancers, 15(5), 1397.
https://doi.org/10.3390/cancers15051397
